neuroblastoma | opacc 2/16

May 29, 2024

Research with mice suggests new treatment for children with neuroblastoma cancer

Researchers are looking for new treatments to increase children’s survival rates from neuroblastoma, a rare solid tumour of young...

May 28, 2024

Scientists discover new insight into the genetic pathway of neuroblastoma

Researchers from the University of Sheffield have created a stem cell model designed to investigate the origins of neuroblastoma, a...

May 24, 2024

Drug targeting RNA modifications shows promise for treating neuroblastoma

New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA...

May 16, 2024

A new era for treating high-risk neuroblastoma – research advances to look out for in 2024

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed...

May 7, 2024

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments...

Apr 19, 2024

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

One of the research focal points of Dr. Josep Samitier's group (Nanobioengineering Group of IBEC), led by Dr. Aránzazu Villasante, is the...

Apr 10, 2024

Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma

A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential....

Mar 28, 2024

A team effort delivers a new tool for fighting neuroblastoma

Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could this...

Mar 26, 2024

Study identifies patients who benefit most from dinutuximab-based immunotherapy

Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the...

Mar 7, 2024

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...

2

Menin inhibitor clinical trial puts pediatric leukemia patient in remission

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Why copper could be key to treating a rare childhood cancer

Innovative surgery preserves limb growth for childhood bone cancer patients

CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset

Global clinical trial shows improved survival rates for common childhood leukemia

More than half of children with cancer die in the hospital

A new CHOP research program is exploring ways to reduce long-term effects of cancer treatment

The ticking ‘epigenetic’ clock measures true biological age

Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors